Clinical Trial Update: Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for everolimus (Certican) in heart and lung transplantation; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Disorder Related to Cardiac Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-04-18